However, when discussing biomarkers for alpha synuclein,1 the authors state that PD and dementia with Lewy bodies (DLB) “have recently been re‐labeled as NSD” (NSD: “neuronal synuclein disease”), and this is repeated throughout the article. The gene discussed is SNCA; the disease is Parkinson disease.